Evidence map›Paper›PMID 32825265›Full record

ArticleNutrients2020

Vitamin D Deficiency in Mexican Pregnant Women: Is Supplementation with ≤400 IU/day Enough?

Otilia Perichart-Perera, Carla Patricia González-Leyva, Isabel González-Ludlow, Maricruz Tolentino-Dolores, Mario Solis-Paredes, Enrique Reyes-Muñoz, Hector Borboa-Olivares, Maribel Sánchez-Martínez, Sandra Parra-Hernández, Eric Monterrubio-Flores and 3 more

Abstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Otilia Perichart-PereraDepartamento de Nutrición y Bioprogramación, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0003-1492-5293
Carla Patricia González-LeyvaDepartamento de Nutrición y Bioprogramación, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Isabel González-LudlowDepartamento de Nutrición y Bioprogramación, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0002-1631-0244
Maricruz Tolentino-DoloresDepartamento de Nutrición y Bioprogramación, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Mario Solis-ParedesDepartamento de Genética y Genómica Humana, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0003-4529-8296
Enrique Reyes-MuñozCoordinación de Endocrinología Ginecológica y Perinatal, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-5304-7476
Hector Borboa-OlivaresSubdirección de Investigación en Intervenciones Comunitarias, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Maribel Sánchez-MartínezDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Sandra Parra-HernándezDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Eric Monterrubio-FloresCentro de Investigación en Nutrición y Salud, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.ORCID 0000-0003-1417-9243
Lourdes Schnaas Y ArrietaDepartamento de Neurobiología del Desarrollo, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Mario Guzmán-HuertaDepartamento de Medicina Traslacional, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Guadalupe Estrada-GutierrezDirección de Investigación, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-9551-9021

Funding

Consejo Nacional de Ciencia y Tecnología 2015-3-261661Instituto Nacional de Perinatologia 3300-11402-01-575-17
6 · The paper itself

Abstract

Controversy remains surrounding vitamin D routine supplementation in healthy pregnancy, and the doses are unclear. The aim of this study was to describe maternal vitamin D status throughout pregnancy in a group of Mexican women and evaluate the effect of frequently prescribed doses of vitamin D3 on longitudinal 25-OH-D concentrations, adjusting for obesity, season, and other factors. We conducted a cohort study (Instituto Nacional de Perinatología-INPer) (2017-2020)) of healthy pregnant women without complications. Pregestational overweight/obesity (body mass index ≥ 25), vitamin D3 supplementation (prescribed by physician; 0-250, 250-400, and >400 IU/day), and serum 25-OH-D concentrations (ELISA) were evaluated in each trimester of pregnancy. Vitamin D deficiency or insufficiency was computed (<20 and <30 ng/mL, respectively). We studied 141 adult women; 58.5% had pregestational obesity or overweight. In the first trimester, 45.8% of the women were supplemented with vitamin D3; 51.4% had vitamin D insufficiency and 37.3%, deficiency. In the third trimester, 75.4% of the women were supplemented, and 20% of them still had deficiency. The final general mixed linear model showed that 25-OH-D significantly increased throughout pregnancy (

Indexed as

Dietary SupplementsNutritional RequirementsPregnant PeopleCholecalciferolCohort StudiesFemaleHumansMaternal Nutritional Physiological PhenomenaMexicoPregnancyPregnancy ComplicationsPregnancy in ObesityPrevalenceVitamin DVitamin D Deficiency25-hydroxyvitamin DCholecalciferolVitamin Dpregnancyserum 25-OH-Dvitamin D3vitamin D status

Identifiers

PMID32825265
PMCPMC7551079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.